Browse > Article
http://dx.doi.org/10.5125/jkaoms.2016.42.3.162

Oral surgery under local anesthesia with dexmedetomidine sedation in a morbidly obese patient with aortic dissection  

Seto, Mika (Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Fukuoka University)
Matsuda, Michitaka (Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Fukuoka University)
Narihira, Kyoichi (Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Fukuoka University)
Kikuta, Toshihiro (Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Fukuoka University)
Publication Information
Journal of the Korean Association of Oral and Maxillofacial Surgeons / v.42, no.3, 2016 , pp. 162-165 More about this Journal
Abstract
We report a case of a morbidly obese man with an aortic aneurysm, in whom dental surgery was performed before elective cardiac surgery. His aortic aneurysm required emergency surgery. However, because of his morbid obesity, elective cardiac surgery was planned. Considering the high risk of infective endocarditis, dental surgery was required. Our patient was at a high risk of aortic rupture caused by hypertension and breathing difficulty in the supine position. Dexmedetomidine (DEX) is an anti-anxiety, sedative, and analgesic medicine that can stabilize circulatory dynamics and minimize blood pressure fluctuations. We administered intravenous DEX for sedation of the patient in Fowler's position. In conclusion, our understanding of the risk factors of DEX enabled us to perform safe invasive oral treatment.
Keywords
Aortic aneurysm; Morbid obesity; Oral surgical procedures; Local anesthetics;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Paris A, Tonner PH. Dexmedetomidine in anaesthesia. Curr Opin Anaesthesiol 2005;18:412-8.   DOI
2 Lands AM. The pharmacological activity of epinephrine and related dihydroxyphenylalkylamines. Pharmacol Rev 1949;1:279-309.
3 Montazem A. Antibiotic prophylaxis in dentistry. Mt Sinai J Med 1998;65:388-92.
4 Michel PL, Acar J. Native cardiac disease predisposing to infective endocarditis. Eur Heart J 1995;16 Suppl B:2-6.
5 Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/ STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010;121:e266-369.   DOI
6 Hagl C, Khaladj N, Peterss S, Bonz A, Pichlmaier M, Haverich A, et al. Treatment of acute aortic dissection type A (AADA): technical considerations. Vasa 2010;39:212-8.   DOI
7 Cormack JR, Orme RM, Costello TG. The role of alpha2-agonists in neurosurgery. J Clin Neurosci 2005;12:375-8.   DOI